Enterprise Value

34.78M

Cash

7.436M

Avg Qtr Burn

-1.59M

Short % of Float

0.19%

Insider Ownership

21.23%

Institutional Own.

11.93%

Qtr Updated

04/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
CPI-613 (devimistat) Details
Solid tumor/s, Pancreatic cancer, Cancer

Failed

Discontinued

Failed

Discontinued

CPI-613 (devimstat) Details
Blood cancer, Cancer, Leukemia, Lymphoma

Failed

Discontinued

CPI-613 (devimstat) Details
Blood cancer, Cancer, Acute myeloid leukemia

Failed

Discontinued

CPI-613 (devimstat) Details
Solid tumor/s, Pancreatic cancer, Cancer

Failed

Discontinued